By targeting a newly uncovered weakness in prostate cancer cells, this could offer an improved treatment for the disease.

Imagine a future where the moment you’re born, a virtual avatar is created and steadily filled with personalised information that is used to assess your cancer risk at each stage of life.

A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor ...

Alpenglow Biosciences, a leader in AI-powered 3D pathology, today announced a strategic agreement with Virdx, a biophysics AI ...

In an analysis of more than half a million men with hypogonadism, testosterone replacement therapy is tied to a 16% lower ...

Former UK prime minister Rishi Sunak has called for a targeted prostate cancer screening program for men most at high risk of the disease, reviving a national debate on how to save more lives and ...

Former President Joe Biden's treatment for an aggressive form of prostate cancer has entered a new phase. A spokesperson says ...

Dr. Wallen: When the prostate cancer is only in the prostate and hasn't spread elsewhere, the standard of care treatments are ...

Alpenglow Biosciences collaborates with Virdx to advance AI-enabled prostate cancer diagnostics: Seattle Thursday, October 9, 2025, 09:00 Hrs [IST] Alpenglow Biosciences, a leader ...

Watch parts 1, 2, and 3 of our conversation with Dr Collins.

Minimally invasive therapy has fewer side effects, hospital says Columbia Memorial Hospital is expanding its robotic-assisted ...

Learn more about prostate cancer and why there is a debate over whether or not patients should get tested for it.